Tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Josefcs
dc.contributor.authorŠámal Vladimírcs
dc.contributor.authorBartoš Jiřícs
dc.date.accessioned2021-01-14T18:07:29Z
dc.date.available21-55-2020en
dc.date.available2021-01-14T18:07:29Z
dc.date.issued2020cs
dc.date.updated21-57-2020en
dc.format.extent6cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/158706
dc.language.isoczecs
dc.publisher.cityPrahacs
dc.relation.ispartofFarmakoterapieen
dc.relation.ispartofseries0cs
dc.subjecttyrosine kinase inhibitorscs
dc.subjectmetastatic renal cell carcinomacs
dc.subjectsunitinibcs
dc.subjectpazopanibcs
dc.subjectcabozantinibcs
dc.subjectimmunotherapycs
dc.subjectprognostic groupcs
dc.subjectline of treatmentcs
dc.titleTyrosine kinase inhibitors in the treatment of metastatic renal cell carcinomaen
dc.titleTyrosinkinázové inhibitory v léčbě metastatického karcinomu ledvinycs
local.citation.epage685-690cs
local.citation.spage685-690cs
local.identifier.publikace8033
local.relation.issue5cs
Files
Collections